The Current Ratio as of September 2024 (TTM) for NLS Pharmaceutics AG (NLSP) is 0.23

According to NLS Pharmaceutics AG’s latest financial reports and current stock price. The company's current Current Ratio is 0.23. This represents a change of -77.82% compared to the average of 1.04 of the last 4 quarters.

NLS Pharmaceutics AG (NLSP) Historical Current Ratio (quarterly & annually)

How has NLSP Current Ratio performed in the past?

The mean historical Current Ratio of NLS Pharmaceutics AG over the last ten years is 1.12. The current 0.23 Current Ratio has changed 1.96% with respect to the historical average. Over the past ten years (40 quarters), NLSP's Current Ratio was at its highest in in the June 2021 quarter at 6.91. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

NLS Pharmaceutics AG (NLSP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NLS Pharmaceutics AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NLS Pharmaceutics AG (NLSP) Average Current Ratio

How has NLSP Current Ratio performed in the past?

The current Current Ratio of NLS Pharmaceutics AG (NLSP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NLS Pharmaceutics AG (NLSP) Current Ratio vs. Peers

How is NLSP’s Current Ratio compared to its peers?

NLS Pharmaceutics AG’s Current Ratio is less than NeuroBo Pharmaceuticals, Inc. (2.94), less than Indaptus Therapeutics, Inc. (3.88), less than Pasithea Therapeutics Corp. (6.20), less than Quoin Pharmaceuticals, Ltd. (3.35), less than Lixte Biotechnology Holdings, Inc. (6.33), less than Anebulo Pharmaceuticals, Inc. (5.32), less than NervGen Pharma Corp. (1.78), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Protagenic Therapeutics, Inc. (2.03), less than Miromatrix Medical Inc. (3.46), less than Rezolute, Inc. (11.82), greater than HCW Biologics Inc. (0.10), less than Eliem Therapeutics, Inc. (60.41), less than Molecular Partners AG (14.58), less than Assembly Biosciences, Inc. (2.74), less than Neoleukin Therapeutics, Inc. (15.33), less than Instil Bio, Inc. (15.06), less than CytomX Therapeutics, Inc. (1.00), less than Achilles Therapeutics plc (8.24),

Build a custom stock screener for NLS Pharmaceutics AG (NLSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NLS Pharmaceutics AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NLS Pharmaceutics AG (NLSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NLS Pharmaceutics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.